DK154503C - Analogifremgangsmaade til fremstilling af 5-(2-((2,3-dihydro-1,4-benzodioxan-2-ylmethyl)-amino)-1-hydroxyethyl)-2-hydroxybenzoesyre-forbindelser eller syreadditionssalte deraf - Google Patents

Analogifremgangsmaade til fremstilling af 5-(2-((2,3-dihydro-1,4-benzodioxan-2-ylmethyl)-amino)-1-hydroxyethyl)-2-hydroxybenzoesyre-forbindelser eller syreadditionssalte deraf

Info

Publication number
DK154503C
DK154503C DK193580A DK193580A DK154503C DK 154503 C DK154503 C DK 154503C DK 193580 A DK193580 A DK 193580A DK 193580 A DK193580 A DK 193580A DK 154503 C DK154503 C DK 154503C
Authority
DK
Denmark
Prior art keywords
acid
hydroxybenzoeoic
benzodioxan
ylmethyl
dihydro
Prior art date
Application number
DK193580A
Other languages
Danish (da)
English (en)
Other versions
DK193580A (da
DK154503B (da
Inventor
J Martin Grisar
Original Assignee
Richardson Merrell Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richardson Merrell Inc filed Critical Richardson Merrell Inc
Publication of DK193580A publication Critical patent/DK193580A/da
Publication of DK154503B publication Critical patent/DK154503B/da
Application granted granted Critical
Publication of DK154503C publication Critical patent/DK154503C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D319/00Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/101,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/141,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/161,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/201,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring with substituents attached to the hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
DK193580A 1979-05-04 1980-05-01 Analogifremgangsmaade til fremstilling af 5-(2-((2,3-dihydro-1,4-benzodioxan-2-ylmethyl)-amino)-1-hydroxyethyl)-2-hydroxybenzoesyre-forbindelser eller syreadditionssalte deraf DK154503C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/036,243 US4206125A (en) 1979-05-04 1979-05-04 5-[2-[(2,3-Dihydro-1,4-benzodioxan-2-ylmethyl)amino]-1-hydroxyethyl]-2-hydroxybenzoic acid derivatives
US3624379 1979-05-04

Publications (3)

Publication Number Publication Date
DK193580A DK193580A (da) 1980-11-05
DK154503B DK154503B (da) 1988-11-21
DK154503C true DK154503C (da) 1989-04-10

Family

ID=21887496

Family Applications (1)

Application Number Title Priority Date Filing Date
DK193580A DK154503C (da) 1979-05-04 1980-05-01 Analogifremgangsmaade til fremstilling af 5-(2-((2,3-dihydro-1,4-benzodioxan-2-ylmethyl)-amino)-1-hydroxyethyl)-2-hydroxybenzoesyre-forbindelser eller syreadditionssalte deraf

Country Status (21)

Country Link
US (1) US4206125A (xx)
JP (1) JPS55147274A (xx)
AT (1) AT369365B (xx)
AU (1) AU531739B2 (xx)
BE (1) BE883087A (xx)
CA (1) CA1148963A (xx)
CH (1) CH645372A5 (xx)
DE (1) DE3014738A1 (xx)
DK (1) DK154503C (xx)
ES (1) ES8104997A1 (xx)
FR (1) FR2455598A1 (xx)
GB (1) GB2051780B (xx)
IE (1) IE49564B1 (xx)
IL (1) IL59681A (xx)
IT (1) IT1127441B (xx)
NL (1) NL8002208A (xx)
NO (1) NO153572C (xx)
NZ (1) NZ193236A (xx)
PH (1) PH15963A (xx)
SE (1) SE434745B (xx)
ZA (1) ZA801603B (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU204285B (en) * 1986-10-31 1991-12-30 Pfizer Process for producing renin-inhibiting polypeptides of small molecule mass and pharmaceutical compositions containing them
JP2931986B2 (ja) * 1989-02-17 1999-08-09 武田薬品工業株式会社 アラルキルアミン誘導体
ES2291733T3 (es) * 2002-10-22 2008-03-01 Glaxo Group Limited Compuestos de ariletanolamina medicinales.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1054104A (xx) * 1962-07-20
US3514465A (en) * 1966-12-30 1970-05-26 Degussa Certain thiazolyl- and pyridinylaminoketones
US3883560A (en) * 1973-07-05 1975-05-13 Colgate Palmolive Co Salicylamidophenethanolamines
CA1147342A (en) * 1977-10-12 1983-05-31 Kazuo Imai Process of producing novel phenylethanolamine derivatives
JPS55124742A (en) * 1979-03-20 1980-09-26 Kyowa Hakko Kogyo Co Ltd Novel aminoalcohol derivative

Also Published As

Publication number Publication date
IL59681A0 (en) 1980-06-30
CA1148963A (en) 1983-06-28
NO801296L (no) 1980-11-05
CH645372A5 (de) 1984-09-28
AT369365B (de) 1982-12-27
AU531739B2 (en) 1983-09-01
IT8048373A0 (it) 1980-04-09
IE49564B1 (en) 1985-10-30
ES490814A0 (es) 1981-05-16
IE800572L (en) 1980-11-04
FR2455598B1 (xx) 1983-05-27
SE8003243L (sv) 1980-11-05
DE3014738A1 (de) 1980-11-13
AU5707780A (en) 1980-11-06
ZA801603B (en) 1981-03-25
GB2051780A (en) 1981-01-21
JPS642115B2 (xx) 1989-01-13
FR2455598A1 (fr) 1980-11-28
NZ193236A (en) 1982-09-14
NO153572C (no) 1986-04-16
GB2051780B (en) 1982-12-22
DE3014738C2 (xx) 1989-08-03
NL8002208A (nl) 1980-11-06
ATA232780A (de) 1982-05-15
BE883087A (fr) 1980-09-01
DK193580A (da) 1980-11-05
DK154503B (da) 1988-11-21
PH15963A (en) 1983-05-04
IT1127441B (it) 1986-05-21
SE434745B (sv) 1984-08-13
ES8104997A1 (es) 1981-05-16
IL59681A (en) 1984-04-30
NO153572B (no) 1986-01-06
US4206125A (en) 1980-06-03
JPS55147274A (en) 1980-11-17

Similar Documents

Publication Publication Date Title
DK151884C (da) Analogifremgangsmaade til fremstilling af 3-(1-imidazolylalkyl)indolderivater eller farmaceutisk acceptable syreadditionssalte deraf
DK462380A (da) Analogifremgangsmaade til fremstilling af 2,4-diaminoquinazolin-forbindelser eller syreadditionssalte deraf
DK160940C (da) Analogifremgangsmaade til fremstilling af benzoheterocycliske forbindelser eller farmaceutisk acceptable salte deraf
DK155048C (da) Analogifremgangsmaade til fremstilling af 1,8-naphthyridinforbindelser
DK149057C (da) Analogifremgangsmaade til fremstilling af 4-(4,4-(diphenyl)butyl)-1-piperazincarboxamider eller -carbothioamider eller syreadditionssalte deraf
DK162714C (da) Analogifremgangsmaade til fremstilling af glycinamidderivater eller syreadditionssalte deraf
DK147362C (da) Analogifremgangsmaade til fremstilling af ergolen- eller ergolin-derivater eller syreadditionssalte deraf
DK148477C (da) Analogifremgangsmaade til fremstilling af tetrahydropyridinylindolderivater eller additionssalte deraf
DK160092C (da) Analogifremgangsmaade til fremstilling af 2-(2-(1,4-benzodioxanyl))-2-imidazolin eller ikke-toxiske syreadditionssalte deraf
DK151017C (da) Analogifremgangsmaade til fremstilling af substituerede n-(4-indolyl-piperidino-alkyl)-benzimidazoloner eller fysiologisk acceptable syreadditionssalte deraf
DK142544C (da) Analogifremgangsmaade til fremstilling af 2-(n-propargyl-n-phenylamino)-imidazolin-(2)-derivater eller fysiologisk acceptable syreadditionssalte heraf
DK134580A (da) Fremgangsmaade til fremstilling af 2,6-diaminonebulariner eller syreadditionssalte deraf
DK157451C (da) Analogifremgangsmaade til fremstilling af 2,4-diamino-6-alkoxybenzyl-5-methylpyridooe2,3-daapyrimidiner eller farmaceutisk acceptable syreadditionssalte deraf
DK430379A (da) Fremgangsmaade til fremstilling af 2,6-diaminonebulariner eller syreadditionssalte deraf
DK533881A (da) Fremgangsmaade til fremstilling af 3,4-bis-substituerede 1,2,5-oxidazol-2-oxider eller farmekologisk acceptable syreadditionsforbindelser
DK154503C (da) Analogifremgangsmaade til fremstilling af 5-(2-((2,3-dihydro-1,4-benzodioxan-2-ylmethyl)-amino)-1-hydroxyethyl)-2-hydroxybenzoesyre-forbindelser eller syreadditionssalte deraf
DK152427C (da) Analogifremgangsmaade til fremstilling af 4-thiomethylpyridinforbindelser eller farmaceutisk acceptable syreadditionssalte deraf
DK158227C (da) Analogifremgangsmaade til fremstilling af substituerede imidazooe1,5-aaapyridiner eller 5,6,7,8-tetrahydroderivater deraf eller salte deraf
DK152754C (da) Analogifremgangsmaade til fremstilling af 1-acyl-8-(3-amino-2-hydroxypropoxy)-1,2,3,4-tetrahydroquinoliner eller farmaceutisk acceptable syreadditionssalte deraf
DK148036C (da) Analogifremgangsmaade til fremstilling af epimere 4''-amino-erythromycin-forbindelser eller syreadditionssalte deraf
DK455980A (da) Analogifremgangsmaade til fremstilling af spiroimidazolonforbindelser eller syreaddiionssalte deraf
DK149889C (da) Analogifremgangsmaade til fremstilling af dibenzo(d,g)(1,3,6)dioxazocinderivater eller syreadditionssalte deraf
DK422879A (da) Fremgangsmaade til fremstilling af n-(1-methyl-2-pyrrolidinylmethyl)-2,3-dimethoxy-5-methylsulfamoyl-benzamid eller derivater deraf
DK516480A (da) Fremgangsmaade til fremstilling af 2-amino-ethanol-derivater eller syreadditionssalte deraf
DK146537C (da) Analogifremgangsmaade til fremstilling af spiro-quinolon-hydantoinforbindelser eller syreadditionssalte deraf

Legal Events

Date Code Title Description
PUP Patent expired